Antiepileptic drug use in seven electronic health record databases in Europe: A methodologic comparison

被引:31
作者
de Groot, Mark C. H. [1 ]
Schuerch, Markus [2 ]
de Vries, Frank [1 ,3 ]
Hesse, Ulrik [4 ]
Oliva, Belen [5 ]
Gil, Miguel [5 ]
Huerta, Consuelo [5 ]
Requena, Gema [6 ]
de Abajo, Francisco [6 ,7 ]
Afonso, Ana S. [1 ]
Souverein, Patrick C. [1 ]
Alvarez, Yolanda [8 ]
Slattery, Jim [8 ]
Rottenkolber, Marietta [9 ]
Schmiedl, Sven [10 ,11 ]
Van Dijk, Liset [1 ,12 ]
Schlienger, Raymond G. [13 ]
Reynolds, Robert [14 ]
Klungel, Olaf H. [1 ]
机构
[1] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Fac Sci, POB 80082, NL-3508 TB Utrecht, Netherlands
[2] F Hoffmann La Roche, Epidemiol Patient Reported Outcomes & Healthcare, Basel, Switzerland
[3] Maastricht Univ Med Ctr, Dept Clin Pharm & Toxicol, Maastricht, Netherlands
[4] Natl Inst Hlth Data & Dis Control, Copenhagen, Denmark
[5] Agencia Espanola Medicamentos & Prod Sanitarios, Madrid, Spain
[6] Univ Alcala, Pharmacol Sect, Dept Biomed Sci 2, Madrid, Spain
[7] Univ Hosp Principe Asturias, Clin Pharmacol Unit, Madrid, Spain
[8] European Med Agcy, London, England
[9] Univ Munich, Inst Med Informat Sci Biometry & Epidemiol, Munich, Germany
[10] Univ Witten Herdecke, Fac Hlth, Sch Med, Dept Clin Pharmacol, Witten, Germany
[11] Helios Clin Wuppertal, Philipp Klee Inst Clin Pharmacol, Wuppertal, Germany
[12] Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands
[13] Novartis Pharma AG, Global Clin Epidemiol, Basel, Switzerland
[14] Pfizer Inc, Epidemiol, New York, NY USA
关键词
Antiepileptic drug use; Drug safety; Epidemiology; Healthcare databases; EPILEPSY; DISORDERS; PATTERNS; CHILDREN;
D O I
10.1111/epi.12557
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
ObjectiveThe annual prevalence of antiepileptic drug (AED) prescribing reported in the literature differs considerably among European countries due to use of different type of data sources, time periods, population distribution, and methodologic differences. This study aimed to measure prevalence of AED prescribing across seven European routine health care databases in Spain, Denmark, The Netherlands, the United Kingdom, and Germany using a standardized methodology and to investigate sources of variation. MethodsAnalyses on the annual prevalence of AEDs were stratified by sex, age, and AED. Overall prevalences were standardized to the European 2008 reference population. ResultsPrevalence of any AED varied from 88 per 10,000 persons (The Netherlands) to 144 per 10,000 in Spain and Denmark in 2001. In all databases, prevalence increased linearly: from 6% in Denmark to 15% in Spain each year since 2001. This increase could be attributed entirely to an increase in new, recently marketed AEDs while prevalence of AEDs that have been available since the mid-1990s, hardly changed. AED use increased with age for both female and male patients up to the ages of 80 to 89years old and tended to be somewhat higher in female than in male patients between the ages of 40 and 70. No differences between databases in the number of AEDs used simultaneously by a patient were found. SignificanceWe showed that during the study period of 2001-2009, AED prescribing increased in five European Union (EU) countries and that this increase was due entirely to the newer AEDs marketed since the 1990s. Using a standardized methodology, we showed consistent trends across databases and countries over time. Differences in age and sex distribution explained only part of the variation between countries. Therefore, remaining variation in AED use must originate from other differences in national health care systems. A PowerPoint slide summarizing this article is available for download in the Supporting Information section .
引用
收藏
页码:666 / 673
页数:8
相关论文
共 24 条
[1]  
Abbing-Karahagopian V, 2013, CURR CLIN PHARM
[2]   Newer and older antiepileptic drug use in Southern Italy: A population-based study during the years 2003-2005 [J].
Alacqua, Marianna ;
Trifiro, Gianluca ;
Spina, Edoardo ;
Moretti, Salvatore ;
Tari, Daniele Ugo ;
Bramanti, P. ;
Caputi, Achille P. ;
Arcoraci, Vincenzo .
EPILEPSY RESEARCH, 2009, 85 (01) :107-113
[3]  
[Anonymous], COMP DAT MED REC PRI
[4]  
Baillargeon J, 1999, AM J IND MED, V35, P343, DOI 10.1002/(SICI)1097-0274(199904)35:4<343::AID-AJIM4>3.0.CO
[5]  
2-4
[6]   Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines [J].
Beghi, E .
LANCET NEUROLOGY, 2004, 3 (10) :618-621
[7]   An algorithm to identify medical practices common to both the General Practice Research Database and The Health Improvement Network database [J].
Cai, Bing ;
Xu, Weifeng ;
Bortnichak, Edward ;
Watson, Douglas J. .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 (07) :770-774
[8]   Use of Antiepileptic drugs for nonepileptic conditions: psychiatric disorders and chronic pain [J].
Ettinger, Alan B. ;
Argoff, Charles E. .
NEUROTHERAPEUTICS, 2007, 4 (01) :75-83
[9]   Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany-a nationwide population-based study in children and adults [J].
Hamer, Hajo M. ;
Dodel, Richard ;
Strzelczyk, Adam ;
Balzer-Geldsetzer, Monika ;
Reese, Jens-Peter ;
Schoeffski, Oliver ;
Graf, Wolfgang ;
Schwab, Stefan ;
Knake, Susanne ;
Oertel, Wolfgang H. ;
Rosenow, Felix ;
Kostev, Karel .
JOURNAL OF NEUROLOGY, 2012, 259 (11) :2376-2384
[10]   Comparison of antiepileptic drug prescribing in children in three European countries [J].
Hsia, Yingfen ;
Neubert, Antje ;
Sturkenboom, Miriam C. J. M. ;
Murray, Macey L. ;
Verhamme, Katia M. C. ;
Sen, Fatma ;
Giaquinto, Carlo ;
Ceci, Adriana ;
Wong, Ian C. K. .
EPILEPSIA, 2010, 51 (05) :789-796